Institution Name

Henry Ford Hospital

Program Types

PGY1 Pharmacy Practice

PGY1 and PGY2 Pharmacotherapy

PGY2 Ambulatory Care

PGY2 Critical Care

PGY2 Infectious Disease

PGY2 Oncology

PGY2 Solid Organ Transplant

PGY2 Thrombosis and Hemostasis Management

Fellowship Infectious Disease Pharmacotherapy Outcomes

PGY1/PGY2 Supply Chain (CPAL) Residency with Cencora

Location

Detroit, Michigan

Overview of Key Training Areas

Henry Ford Hospital is a tertiary care, academic medical center with many national specialty certifications including ambulatory care, cardiology, critical care, infectious diseases, neurology, oncology, surgery, and solid organ transplantation.

Unique Perspectives and Fun Facts

Pharmacy residency training at Henry Ford Hospital started in 1980, and we currently have a total of 23 residents per year. Distinct aspects of the program include a longitudinal research program, unique presentation experiences, an option to complete a teaching certificate program, an on-call program, and a structured process to train residents’ response to medical emergencies. Clinical pharmacy practice at Henry Ford Hospital has existed for over 40 years, and pharmacists practice at the top of their license with the ability to modify pharmacotherapy through dosing protocols within the hospital setting and collaborative practice agreements in the ambulatory setting.

Recent Resident/Fellow Achievements

Publications:

1. Ferrari HM, Kale-Pradhan P, Konja J, et al. Systemic-sclerosis-related interstitial lung disease: a review of the literature and recommended approach for clinical pharmacists. Ann Pharmacother. 2024;58(9):956-971. https://doi.org/10.1177/10600280231213672 
2. Nardolillo JA, Lobkovich A, Berlie H, Konja J, et al. Evaluation of an ambulatory care elective to improve practice readiness perceptions utilizing entry-level competencies. Curr Pharm Teach Learn. 2024;16(3):184-195. https://doi.org/10.1016/j.cptl.2023.12.021
3. Arena CJ, Veve MP, Fried ST, Ware F, Lee P, Shallal AB. Navigating performance measures for ambulatory antimicrobial stewardship: a review of HEDIS® and other metrics the steward should know. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e217. https://doi.org/10.1017/ash.2024.468
4. Arena CJ, Kenney RM, Ramesh M, Davis SL, Veve MP. Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infection. Int J Infect Dis. 2025;151:107314. https://doi.org/10.1016/j.ijid.2024.107314
5. Arena CJ, Kenney RM, Eriksson E, Brar I, Veve MP. Prescribing practices of recommended treatment for Trichomonas vaginalis and Chlamydia trachomatis after 2021 STI treatment guideline update. Sex Transm Dis. 2024;51(11):e40-e42. https://doi.org/10.1097/OLQ.0000000000001987
6. Arena CJ, Kenney RM, Kendall RE, Tibbetts RJ, Veve MP. Respiratory culture nudge improves antibiotic prescribing for Moraxella catarrhalis and Haemophilus influenzae lower respiratory tract infections. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e23. https://doi.org/10.1017/ash.2023.1
7. Boettcher SR, Kenney RM, Arena CJ, et al. Say it ain’t Steno: a microbiology nudge comment leads to less treatment o f Stenotrophomonas maltophilia respiratory colonization. Infect Control Hosp Epidemiol. 2024 Dec 3:1-5. https://doi.org/10.1017/ice.2024.19
8. Campillo-Terrazas W, et al. Judicious use of benzathine penicillin G in response to a medication alert during a critical drug shortage. J Pharm Technol. 2024 Oct 11:87551225241285317. https://doi.org/10.1177/87551225241285317
9. Mulbah JL, et al. Ceftriaxone versus cefepime or carbapenems for definitive treatment of low-risk AmpC-harboring Enterobacterales bloodstream infections in hospitalized adults: a retrospective cohort study. Diagn Microbiol Infect Dis. Published online October 13, 2024. https://doi.org/10.1016/j.diagmicrobio.2024.116557
10. Hardy ME, et al. Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales. Antimicrob Agents Chemother. 2023;67(11):e0082623. https://doi.org/10.1128/aac.00826-23
11. de Oca JEM, et al. Aminopenicillins vs non-aminopenicillins for treatment of enterococcal lower urinary tract infections. Int J Antimicrob Agents. 2023;61(6):106800. https://doi.org/10.1016/j.ijantimicag.2023.106800
12. Mercuro NJ, Medler CJ, et al. Pharmacist-driven transitions of care practice model for prescribing oral antimicrobials at hospital discharge. JAMA Netw Open. 2022;5(5):e2211331. https://doi.org/10.1001/jamanetworkopen.2022.11331
13. Vuong L, et al. Implementation of indication-based antibiotic order sentences improves antibiotic use in emergency departments. Am J Emerg Med. 2023;69:5-10. https://doi.org/10.1016/j.ajem.2023.03.048
14. Ho TA, et al. Cancer is chronic but antimicrobial stewardship is iconic: a retrospective cohort of optimal antibiotic use in ambulatory oncology clinics. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e81. https://doi.org/10.1017/ash.2023.152
15. Belza-Mai AC, et al. Optimizing discharge antimicrobial therapy: evaluation of a transitions of care process and electronic scoring system for patients with community-acquired pneumonia or chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2024;81(24):1237-1244. https://doi.org/10.1093/ajhp/zxae174
16. Vandervelde R, et al. Impact of time to treatment in first occurrence, non-severe Clostridioides difficile infection for elderly patients: are we waiting too long to treat? Antimicrob Steward Healthc Epidemiol. 2024;4(1):e59. https://doi.org/10.1017/ash.2024.46
17. Greenlee SB, et al. Bridging the gap: an approach to reporting antimicrobial stewardship metrics specific to solid organ transplant recipients. Transpl Infect Dis. 2022;24(5):e13944. https://doi.org/10.1111/tid.13944
18. Greenlee SB, et al. Evaluating the impact of substance use disorder resources on outcomes of persons who inject drugs with infections. J Addict Med. 2023;17(1):104-107. https://doi.org/10.1097/ADM.0000000000001028
19. Kaur S, Hutton M, Medler C, et al. The long-term sustainability of a respiratory culture nudge. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e15. https://doi.org/10.1017/ash.2022.5
20. Morrison AR, et al. Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis. Diagn Microbiol Infect Dis. 2022;102(1):115571. https://doi.org/10.1016/j.diagmicrobio.2021.115571
21. Gill CM, et al. High-dose daptomycin is well tolerated via 2-minute IV push administration. Hosp Pharm. 2021;56(4):328-331. https://doi.org/10.1177/0018578719897076
22. Mercuro NJ, et al. Impact of unit-specific metrics and prescribing tools on a family medicine ward. Infect Control Hosp Epidemiol. 2020;41(11):1272-1278. https://doi.org/10.1017/ice.2020.288
23. Morrison AR, et al. Outpatient Clostridioides difficile infections: an opportunity for antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2020;41(8):969-971. https://doi.org/10.1017/ice.2020.199
24. Mercuro NJ, Gill CM, et al. Treatment and outcomes of Enterococcus faecium bloodstream infections in solid organ transplant recipients. Transpl Infect Dis. 2020;22(2):e13251. https://doi.org/10.1111/tid.13251
25. Bianchini ML, et al. Discharge delays and costs associated with outpatient parenteral antimicrobial therapy for high-priced antibiotics. Clin Infect Dis. 2020;71(7):e88-e93. https://doi.org/10.1093/cid/ciz1076
26. Hutton M, et al. Influence of body weight category on outcomes in candidemia patients treated with anidulafungin. J Pharm Pract. 2022;35(1):20-25. https://doi.org/10.1177/0897190020938219
27. Fronrath MJ, et al. Fluid resuscitation and relation to respiratory support escalation in patients with and without pulmonary hypertension with sepsis. Pharmacotherapy. 2024;44(1):61-68.
28. Gutenschwager DW, Patel A, et al. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension center of comprehensive care. Am J Health Syst Pharm. 2024;81(2):66-73.
29. August BA, et al. Evaluating the impact of severe sepsis 3-hour bundle compliance on 28-day in-hospital mortality: a propensity adjusted, nested case-control study. Pharmacotherapy. 2022;42(8):651-658.
30. Baik I, Jantz A, Poparad-Stezar A, Khoury N, Venkat D, Gonzalez H, Samaniego-Picota M, Fitzmaurice MG. Evaluating the use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in a matched cohort of kidney and liver transplant recipients. J Pharm Pract Res. 2024. https://doi.org/10.1002/jppr.1953

Grants:

1. Kelly Kepley, Pharm.D. (PGY2 Ambulatory Care 2024-2025)—ASHP’s 2024 Pharmacy Resident Research Grant
2. William Campillo Terrazas, Pharm.D., MPH (PGY1/2 Pharmacotherapy Resident 2022-2024)—ASHP’s 2024 Pharmacy Resident Research Grant
3. Christen Langley, Pharm.D., MLS (Infectious Disease Fellow 2023-2025)—ASHP’s 2023 Pharmacy Resident Research Grant
4. Christen Arena, Pharm.D., MLS (Infectious Disease Fellow 2023-2025)—Blue Cross Blue Shield of Michigan Foundation 2023
5. Jessica Brochu, Pharm.D. (PGY2 Critical Care 2023-2024)—The PGY2 Critical Care Residency Program was recognized with the ASHP Pharmacist Nutrition Support Patient-Care Impact Program Award for 2023-2024.
6. Anticoagulation Forum TRAIN Grant for establishing a PGY2 Thrombosis and Hemostasis Management residency program; 2023-2025.
7. Anand Patel, Pharm.D. (PGY1 resident) and David Gutenschwager, Pharm.D. (PGY1 resident) received the Shields Health Solutions Resident Research Grant for 2021-2022.
8. Benjamin August, Pharm.D. (PGY2 Critical Care Resident) received the ACCP Critical Care PRN Resident Research Grant for 2020-2021.

Awards:

1. Emma Kabalka, Pharm.D. (PGY1 Resident 2023-2024) received the Gold Snapshot Award at the Society of Critical Care Medicine 2025 Critical Care Congress for her project titled “Incidence of Dexmedetomidine Induced Cardiovascular Adverse Drug Events in Patients with Cirrhosis.”
2. David Gutenschwager, Pharm.D. (PGY2 Critical Care Resident 2022-2023) received the 2023 ACCP Critical Care PRN Resident/Fellow of the Year Award.
3. The PGY2 Residency in Infectious Diseases was awarded the ASHP Foundation Pharmacy Residency Excellence Program Award for 2021.

Personal Perspectives from Current or Past Participants

Training at Henry Ford Hospital has been an incredible opportunity, providing me with hands-on experience in a fast-paced, pharmacy-driven environment. The department’s commitment to advancing patient care has not only challenged my skills but also helped me grow personally by emphasizing compassion in health care. Living in Michigan has been a big change, and I’ve come to appreciate the balance between Detroit’s vibrant energy and the surrounding natural beauty! While the winters can be cold and gloomy, they offer a chance to connect with the local community and culture, making the most of every season!

Stormmy R. Boettcher, Pharm.D.

PGY2 Infectious Diseases Pharmacy Resident (2024-2025)

PGY1 Pharmacy Practice Resident (2023-2024)

Henry Ford Hospital

Completing my PGY1/2 pharmacotherapy residency at Henry Ford Hospital (HFH) was a transformative journey that shaped my career and personal growth. The program’s flexibility allowed me to pursue my passion for infectious diseases while honing the skills and confidence essential for clinical pharmacy. The invaluable mentorship from expert preceptors set a high standard of rigorous yet compassionate training, which continues to inspire me as an educator. HFH also nurtured my passion for teaching through the teaching and learning certificate program, emphasizing mentorship, collaboration, and lifelong learning. Moving from El Paso to Detroit was an adventure, but the kindness and inclusivity I encountered, exemplified by my program director helping me find a winter coat, made the transition unforgettable. The diverse culture and supportive environment of HFH and Detroit taught me adaptability, gratitude, and the importance of human connection, leaving me deeply thankful for these experiences and eager to encourage future residents to embrace all that HFH has to offer.

William Campillo Terrazas, Pharm.D., MPH (Pharmacotherapy Resident 2022-2024)

Clinical Assistant Professor

The University of Texas at El Paso School of Pharmacy

Additional Comments

Henry Ford Hospital in Detroit, Michigan, offers a premier pharmacy residency training experience with access to cutting-edge medical technology, renowned faculty, and a diverse patient population. The hospital is a leader in medical research and innovation, providing trainees with ample opportunities for professional growth. Beyond the hospital, Metro Detroit boasts a rich cultural scene, including world-class museums, vibrant music and arts communities, all major sporting events, and delicious dining options. Outdoor enthusiasts can enjoy Michigan’s picturesque parks, lakes, and recreational activities. Detroit truly is a city that has something for everyone.